News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,237 Results
Type
Article (41816)
Company Profile (329)
Press Release (663092)
Section
Business (210154)
Career Advice (2076)
Deals (36576)
Drug Delivery (96)
Drug Development (82796)
Employer Resources (171)
FDA (16478)
Job Trends (15357)
News (355421)
Policy (33822)
Tag
Academia (2576)
Alliances (51098)
Alzheimer's disease (1247)
Approvals (16409)
Artificial intelligence (140)
Bankruptcy (362)
Best Places to Work (11672)
Biotechnology (214)
Breast cancer (122)
Cancer (1110)
Cardiovascular disease (102)
Career advice (1738)
Cell therapy (239)
Clinical research (65786)
Collaboration (396)
Compensation (202)
COVID-19 (2601)
C-suite (96)
Data (1135)
Diabetes (154)
Diagnostics (6225)
Earnings (86509)
Employer resources (149)
Events (112353)
Executive appointments (318)
FDA (17026)
Funding (360)
Gene therapy (188)
GLP-1 (611)
Government (4447)
Healthcare (18852)
Infectious disease (2686)
Inflammatory bowel disease (110)
Interviews (320)
IPO (16581)
Job creations (4051)
Job search strategy (1487)
Layoffs (433)
Legal (8319)
Lung cancer (172)
Manufacturing (185)
Medical device (13260)
Medtech (13265)
Mergers & acquisitions (20068)
Metabolic disorders (420)
Neuroscience (1531)
NextGen Class of 2024 (6625)
Non-profit (4514)
Northern California (1489)
Obesity (242)
Opinion (203)
Patents (105)
People (58241)
Pharmaceutical (93)
Phase I (20346)
Phase II (28952)
Phase III (21715)
Pipeline (460)
Postmarket research (2644)
Preclinical (8679)
Radiopharmaceuticals (241)
Rare diseases (229)
Real estate (6241)
Regulatory (22368)
Research institute (2360)
Resumes & cover letters (358)
Southern California (1309)
Startups (3713)
United States (13673)
Vaccines (568)
Weight loss (183)
Date
Today (80)
Last 7 days (675)
Last 30 days (3753)
Last 365 days (36252)
2024 (33273)
2023 (40631)
2022 (51798)
2021 (56335)
2020 (54802)
2019 (47407)
2018 (35782)
2017 (33147)
2016 (32667)
2015 (38619)
2014 (32516)
2013 (27632)
2012 (29730)
2011 (30489)
2010 (28500)
Location
Africa (776)
Arizona (199)
Asia (39994)
Australia (6395)
California (3356)
Canada (1301)
China (257)
Colorado (150)
Connecticut (156)
Europe (85151)
Florida (462)
Georgia (116)
Illinois (348)
Indiana (204)
Kansas (96)
Maryland (581)
Massachusetts (2654)
Michigan (159)
Minnesota (274)
New Jersey (972)
New York (968)
North Carolina (720)
Northern California (1489)
Ohio (139)
Pennsylvania (852)
South America (1157)
Southern California (1309)
Texas (475)
Washington State (369)
705,237 Results for "nexus pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Nexus Pharmaceuticals Launches Baclofen Injection, USP
Today, Nexus Pharmaceuticals announced the launch of Baclofen Injection, USP.
March 18, 2024
·
1 min read
Biotech Beach
ONCOTELIC PRESENTING AT BIOPHARMA NEXUS CONFERENCE SAN DIEGO 2024
Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its presentation at Biopharma Nexus Conference.
May 8, 2024
·
4 min read
Policy
Nexus Pharmaceuticals, Inc. Receives Successful FDA Inspection of Pharmaceutical Manufacturing Facility in Pleasant Prairie, Wisconsin
Nexus Pharmaceuticals, Inc. announced that its pharmaceutical manufacturing facility in Pleasant Prairie, Wisconsin, was successfully inspected by the Food and Drug Administration, which will allow Nexus to begin commercial operations.
May 5, 2023
·
2 min read
FDA
Nexus Pharmaceuticals Receives FDA Approval for Fluorescein Injection, USP
Nexus Pharmaceuticals, LLC announced it has received U.S. Food and Drug Administration (FDA) approval for Fluorescein Injection, USP.
September 26, 2023
·
1 min read
Press Releases
Prime Therapeutics bolsters its position as industry leader with 10 research studies at AMCP Nexus 2024
October 10, 2024
·
4 min read
Press Releases
Endospan Completes Enrollment of Primary Arm in NEXUS® Aortic Arch Stent Graft TRIOMPHE IDE Clinical Study
October 21, 2024
·
2 min read
BioCapital
The ALS Association Announces Inaugural ‘ALS Nexus’ Conference
The ALS Association, the leading national non-profit organization dedicated to fighting ALS on every front, is excited to announce its inaugural ALS Nexus Conference, taking place July 14-17, 2024 at The Gaylord Texan Resort & Conference Center in Grapevine, Texas.
March 22, 2024
·
3 min read
BioMidwest
Nexus Pharmaceuticals Announces Launch of Sterile Vial Product Line
Nexus Pharmaceuticals, Inc. announced the launch of its new product line – Sterile Vials from Nexus Pharmaceuticals.
February 22, 2023
·
2 min read
FDA
Nexus Pharmaceuticals Inc. Receives FDA Approval for Tirofiban Hydrochloride Injection
Nexus Pharmaceuticals Inc. announced that it has received US Food and Drug Administration (FDA) approval for Tirofiban Hydrochloride Injection in 5mg/100mL single-dose IV-bags.
February 9, 2023
·
1 min read
Press Releases
Mitsubishi Tanabe Pharma America to Showcase New RADICAVA ORS® (edaravone) Real-World Data at 2024 Academy of Managed Care Pharmacy Nexus Meeting
October 11, 2024
·
6 min read
1 of 70,524
Next
